Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report.
Sebastian SchnaubeltMarie-Kathrin BreyerJolanta M Siller-MatulaHans DomanovitsPublished in: European heart journal. Case reports (2020)
Treatment of acute heart failure in COVID-19 patients with a cytokine storm complicated by tachycardic atrial fibrillation should include adequate rate or rhythm control, and potentially immunomodulation.
Keyphrases
- atrial fibrillation
- acute heart failure
- coronavirus disease
- sars cov
- heart failure
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- direct oral anticoagulants
- percutaneous coronary intervention
- respiratory syndrome coronavirus
- heart rate
- combination therapy
- blood pressure
- mitral valve
- acute coronary syndrome